D.E. Shaw & Co’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.3M | Sell |
891,142
-769,570
| -46% | -$14.6M | 0.01% | 1278 |
|
|
2025
Q4 | $26.2M | Buy |
1,660,712
+349,328
| +27% | +$6.24M | 0.01% | 1074 |
|
|
2025
Q3 | $25.4M | Buy |
1,311,384
+465,873
| +55% | +$9.1M | 0.01% | 1022 |
|
|
2025
Q2 | $17.5M | Sell |
845,511
-137,567
| -14% | -$2.86M | 0.01% | 1122 |
|
|
2025
Q1 | $24M | Buy |
983,078
+726,839
| +284% | +$18.7M | 0.02% | 834 |
|
|
2024
Q4 | $6.13M | Buy |
256,239
+199,671
| +353% | +$6.34M | ﹤0.01% | 1822 |
|
|
2024
Q3 | $2.4M | Sell |
56,568
-73,387
| -56% | -$3.85M | ﹤0.01% | 2579 |
|
|
2024
Q2 | $6.66M | Sell |
129,955
-41,446
| -24% | -$2.35M | 0.01% | 1630 |
|
|
2024
Q1 | $10.7M | Buy |
171,401
+10,202
| +6% | +$694K | 0.01% | 1308 |
|
|
2023
Q4 | $12.1M | Sell |
161,199
-25,010
| -13% | -$1.79M | 0.01% | 1239 |
|
|
2023
Q3 | $15.9M | Sell |
186,209
-14,752
| -7% | -$1.4M | 0.02% | 989 |
|
|
2023
Q2 | $21.9M | Sell |
200,961
-189,330
| -49% | -$17.9M | 0.02% | 813 |
|
|
2023
Q1 | $32.4M | Sell |
390,291
-69,718
| -15% | -$6.56M | 0.03% | 623 |
|
|
2022
Q4 | $47.3M | Sell |
460,009
-58,755
| -11% | -$6.77M | 0.05% | 453 |
|
|
2022
Q3 | $55M | Buy |
518,764
+103,057
| +25% | +$11.3M | 0.07% | 356 |
|
|
2022
Q2 | $45.6M | Buy |
415,707
+159,710
| +62% | +$15.8M | 0.05% | 440 |
|
|
2022
Q1 | $26.7M | Buy |
255,997
+252,595
| +7,425% | +$26.2M | 0.03% | 842 |
|
|
2021
Q4 | $416K | Buy |
+3,402
| New | +$378K | ﹤0.01% | 4507 |
|
|
2021
Q3 | – | Sell |
-40,204
| Closed | -$3.9M | – | 4936 |
|
|
2021
Q2 | $3.9M | Buy |
40,204
+18,933
| +89% | +$1.64M | ﹤0.01% | 2264 |
|
|
2021
Q1 | $1.57M | Buy |
+21,271
| New | +$1.58M | ﹤0.01% | 2786 |
|
|
2015
Q4 | – | Sell |
-233,804
| Closed | -$7.02M | – | 3771 |
|
|
2015
Q3 | $7.02M | Buy |
233,804
+70,428
| +43% | +$2.32M | 0.01% | 1175 |
|
|
2015
Q2 | $5.16M | Buy |
163,376
+62,112
| +61% | +$1.62M | 0.01% | 1440 |
|
|
2015
Q1 | $2.34M | Buy |
101,264
+44,414
| +78% | +$919K | ﹤0.01% | 1887 |
|
|
2014
Q4 | $1.11M | Buy |
56,850
+14,435
| +34% | +$248K | ﹤0.01% | 2748 |
|
|
2014
Q3 | $666K | Buy |
+42,415
| New | +$604K | ﹤0.01% | 3135 |
|
|
2014
Q2 | – | Sell |
-62,834
| Closed | -$863K | – | 4153 |
|
|
2014
Q1 | $863K | Buy |
62,834
+18,029
| +40% | +$260K | ﹤0.01% | 3160 |
|
|
2013
Q4 | $659K | Buy |
+44,805
| New | +$606K | ﹤0.01% | 3522 |
|
Other funds holding AMN
VCM
VPM
D.E. Shaw & Co's AMN Position: Q1 2026 in Review
D.E. Shaw & Co reduced its AMN Healthcare (AMN) stake by 46% in Q1 2026, selling an estimated $14.6M and leaving 891,142 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #1278.
D.E. Shaw & Co first reported a position in AMN in Q4 2013 and has held it in 27 quarters since. The position peaked at $55M in Q3 2022. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- D.E. Shaw & Co held 891,142 shares of AMN Healthcare worth $16.3M as of Q1 2026.
- D.E. Shaw & Co sold 769,570 AMN Healthcare shares in Q1 2026, an estimated $14.6M.
- AMN Healthcare made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1278 holding.
- D.E. Shaw & Co first reported a position in AMN Healthcare in Q4 2013 and has held it in 27 quarters since.
- D.E. Shaw & Co's AMN Healthcare position peaked at $55M in Q3 2022.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.